Controlled-release microchips

Expert Opinion on Drug Delivery
Sadhana SharmaMauro Ferrari

Abstract

Efficient drug delivery remains an important challenge in medicine: continuous release of therapeutic agents over extended time periods in accordance with a predetermined temporal profile; local delivery at a constant rate to the tumour microenvironment to overcome much of the systemic toxicity and to improve antitumour efficacy; improved ease of administration, and increasing patient compliance required are some of the unmet needs of the present drug delivery technology. Microfabrication technology has enabled the development of novel controlled-release microchips with capabilities not present in the current treatment modalities. In this review, the current status and future prospects of different types of controlled-release microchips are summarised and analysed with reference to microneedle-based microchips, as well as providing an in-depth focus on microreservoir-based and nanoporous microchips.

References

Mar 1, 1992·Pharmaceutical Research·S W KimT Okano
Jul 1, 1991·Pharmaceutical Research·A D'Emanuele, J N Staniforth
Aug 31, 1989·The New England Journal of Medicine·C D SaudekM A Charles
Feb 1, 1986·Surgical Neurology·G SalkindA Schut
Feb 1, 1986·IEEE Transactions on Bio-medical Engineering·S L BeMentK L Drake
Jul 29, 1982·The New England Journal of Medicine·W M RuppH Buchwald
Mar 10, 1998·Analytical Chemistry·A T WoolleyR A Mathies
Jun 10, 1998·Controlled Clinical Trials·P Boudes
Aug 4, 1998·Journal of Pharmaceutical Sciences·S HenryM R Prausnitz
Feb 13, 1999·Nature·J T SantiniR Langer
Jul 8, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·M A DewB P Griffith
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·D D Breimer
Nov 27, 1999·IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society·J BrazzleA B Frazier
Apr 13, 2000·Journal of Pain and Symptom Management·K A Follett, C P Naumann
Jul 7, 1997·Advanced Drug Delivery Reviews·W M Saltzman, L K Fung
Aug 18, 2000·Journal of Long-term Effects of Medical Implants·M D FeldmanW D Rosenblum
Oct 6, 2000·Physical Review Letters·L A ClarkR Q Snurr
Feb 13, 2001·Anesthesia and Analgesia·S KaushikM R Prausnitz
Jun 23, 2001·Biosensors & Bioelectronics·T A DesaiM Ferrari
Oct 24, 2001·Advanced Drug Delivery Reviews·T YasukawaY Ogura
Nov 10, 2001·Annual Review of Biomedical Engineering·D V McAllisterM R Prausnitz
Nov 10, 2001·Annual Review of Biomedical Engineering·D L PollaP Krulevitch
Jan 5, 2002·Journal of Biomedical Materials Research·Kameha R KiddStuart K Williams
May 2, 2002·Clinical Transplantation·Lyndsay S BainesRahul M Jindal
Oct 18, 2002·Advanced Drug Delivery Reviews·Zaki MegeedHamidreza Ghandehari
Oct 24, 2002·Advanced Drug Delivery Reviews·S Sershen, J West
Feb 15, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eytan A KlausnerAmnon Hoffman
Mar 12, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sarah L TaoTejal A Desai
Aug 6, 2003·IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·Daryl R KipkeJamille F Hetke
Oct 2, 2003·Nature Materials·Henning Sirringhaus
Nov 19, 2003·Nature Materials·Amy C Richards GraysonRobert Langer
Mar 17, 2004·Advanced Drug Delivery Reviews·Apostolos G Doukas, Nikiforos Kollias
Mar 17, 2004·Advanced Drug Delivery Reviews·Mark R Prausnitz
Mar 17, 2004·Advanced Drug Delivery Reviews·Samir Mitragotri, Joseph Kost
Mar 17, 2004·Advanced Drug Delivery Reviews·Adrian C Williams, Brian W Barry
Mar 17, 2004·Advanced Drug Delivery Reviews·Anne-Rose DenetVéronique Préat
Mar 17, 2004·Advanced Drug Delivery Reviews·Gregor Cevc
Apr 22, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Samuel HassenbuschKenneth Dean Willis
Sep 21, 2004·Biomedical Microdevices·Jeffrey D ZahnDorian Liepmann
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Frank MartinMauro Ferrari
Apr 6, 2005·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·Raja K SivamaniHoward Maibach
May 13, 2005·IEEE Transactions on Bio-medical Engineering·Shawn P DavisMark R Prausnitz

❮ Previous
Next ❯

Citations

Jul 24, 2010·Journal of Materials Science. Materials in Medicine·Teodora ZecheruIzabela-Cristina Stancu
Jul 2, 2010·Pharmaceutical Research·Alessandro GrattoniMauro Ferrari
Sep 1, 2009·Future Medicinal Chemistry·Steven J P McInnes, Nicolas H Voelcker
Mar 8, 2012·Nanomedicine·Steven J P McInnesNicolas H Voelcker
Nov 3, 2006·Expert Review of Neurotherapeutics·Herbert B Newton
Apr 25, 2014·Drug Delivery·Kumar Bishwajit Sutradhar, Chandra Datta Sumi
Dec 15, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Steven James Peter McInnesNicolas H Voelcker
Apr 16, 2013·Advanced Healthcare Materials·Daniel FineMauro Ferrari
Aug 10, 2010·Journal of Biomedical Materials Research. Part a·Biana GodinMauro Ferrari
Jun 22, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Mark Staples
Jul 5, 2016·BioMed Research International·Adam E M EltoraiStephanie Guang
Jun 23, 2012·ACS Applied Materials & Interfaces·Steven J P McInnesNicolas H Voelcker
Aug 24, 2011·Lab on a Chip·Fatemeh Nazly PirmoradiMu Chiao
Dec 21, 2019·International Journal of Pharmaceutics·Shaun W GietmanSimon E Moulton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.